Top

Strahlentherapie und Onkologie

Published in:

01-10-2017 | Literatur kommentiert

Die beste multimodale Therapie beim lokal fortgeschrittenen Nasopharynxkarzinom

Ein Update der MAC-NPC-Daten

Authors: Prof. Dr. Martina Becker-Schiebe, Prof. Dr. Hans Christiansen

Published in: Strahlentherapie und Onkologie | Issue 10/2017

Auszug

Bisherige Daten zum Stellenwert der adjuvanten (AC) oder Induktionschemotherapie (IC) zusätzlich zur kombinierten Radiochemotherapie (RCT) des lokal fortgeschrittenen Nasopharynxkarzinoms (NPC) bleiben widersprüchlich. Mit Hilfe individueller Patientendaten aus der MAC-NPC-Analyse (Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma) wurden verschiedene Behandlungsalgorithmen verglichen. …

Baujat B, Audry H, Bourhis J et al (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64:47–56CrossRefPubMed

Blanchard P, Lee A, Marguet S et al (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16:645–655CrossRefPubMed

Lee AWM, Ng WT, Chan LLK et al (2014) Evolution of treatment for nasopharyngeal cancer – success and setback in the intensity-modulated radiotherapy era. Radiother Oncol 110:377–384CrossRefPubMed

Kwong DL, Sham JS, Au GK et al (2004) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 22:2643–2653CrossRefPubMed

Wu X, Huang PY, Peng PJ et al (2013) Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 24(8):2131–2136CrossRefPubMed

Chen YP, Wang ZX, Chen L et al (2015) A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 26:205–211CrossRefPubMed

Yu H, Gu D, He X et al (2016) The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials. Onco Targets Ther 9:159–170CrossRefPubMedPubMedCentral

Lee AWM, Tung SY, Ngan RKC et al (2011) Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials. Eur J Cancer 47:656–666CrossRefPubMed

Wee JTS, Song Y, Poh S et al (2016) Nasopharyngeal carcinoma-some closing remarks Chinese. Clin Oncol 5:29

10.

Tan T, Lim W‑T, Fong K‑W et al (2015) Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 91:952–960CrossRefPubMed

11.

Kontny U, Franzen S, Behrends U et al (2016) Diagnosis and treatment of Nasopharyngeal carcinoma in children and adolescents – recommendations of the GPOH-NPC study group. Klin Padiatr 228:105–112CrossRefPubMed

12.

Wolff HA, Rödel RM, Gunawan B et al (2010) Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas. J Cancer Res Clin Oncol 136:89–97CrossRefPubMed

Title: Die beste multimodale Therapie beim lokal fortgeschrittenen Nasopharynxkarzinom
Ein Update der MAC-NPC-Daten
Authors: Prof. Dr. Martina Becker-Schiebe
Prof. Dr. Hans Christiansen
Publication date: 01-10-2017
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 10/2017
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-017-1189-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Die beste multimodale Therapie beim lokal fortgeschrittenen Nasopharynxkarzinom

Ein Update der MAC-NPC-Daten

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 10/2017

“Radio-oncomics”

Können 12- statt 4‑wöchentliche Zoledronsäuregaben skelettale Ereignisse bei Patienten mit Knochenmetastasen reduzieren?

21st Annual SASRO Meeting

Interobserver variability in target volume delineation of hepatocellular carcinoma

Optimaler Resektionsrand für die brusterhaltende Operation und Ganzbrustbestrahlung beim duktalen Carcinoma in situ

An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging